Literature DB >> 19262698

Molecular epidemiology of gastric cancer: current status and future prospects.

Zhibin Hu1, Jaffer A Ajani, Qingyi Wei.   

Abstract

Gene-environment interaction appears to contribute to the etiology of gastric cancer, as suggested by the varying geographic patterns of gastric cancer incidence. Even in areas with a high rate Helicobacter pylori (H. pylori) infection, only a small proportion of infected individuals develop gastric cancer. It is likely that genetic factors, particularly relatively common genetic variants, such as single nucleotide polymorphisms (SNPs), may modulate the effects of environmental risk factors by regulating multiple biologic pathways involved in gastric carcinogenesis. Thus, common genetic variants can pose a substantial influence on the population attributable risk, even though the absolute risk associated with each of these variants may be low. Remarkable progress has been made in the field of molecular epidemiology, but it appears that an initial view on the magnitude of the effects of inherited variants was overestimated. Nevertheless, evidence suggests that genetic variants may contribute to the etiology of gastric cancer, particularly those SNPs in genes that are involved in inflammatory response, metabolism of chemical carcinogens, DNA repair, and tumor suppression. Although previous molecular epidemiologic studies of potentially functional polymorphisms in candidate genes and gastric cancer susceptibility lack consistency, they have advanced our knowledge of the role of genetic susceptibility in the etiology of gastric cancer. Future, welldesigned large population-based studies will validate current findings and provide the rationale for identifying at-risk subpopulations for primary prevention of gastric cancer.

Entities:  

Year:  2007        PMID: 19262698      PMCID: PMC2632516     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


  137 in total

1.  Genetic polymorphisms of XRCC1 and risk of gastric cancer.

Authors:  Seong-Gene Lee; Byungsik Kim; Jaewon Choi; Changhoon Kim; Inchul Lee; Kyuyoung Song
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

2.  Cytokine inhibition of gastric acid secretion--a little goes a long way.

Authors:  M M Wolfe; D J Nompleggi
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  Glutathione S-transferase M1 gene null genotype and gastric cancer risk in Taiwan.

Authors:  Kuang-Chi Lai; Wen-Chi Chen; Fuu-Jen Tsai; Shuan-Yow Li; Ming-Chih Chou; Long-Bin Jeng
Journal:  Hepatogastroenterology       Date:  2005 Nov-Dec

4.  Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer.

Authors:  Young-Woon Chang; Jae-Young Jang; Nam-Hoon Kim; Jae Won Lee; Hyo Jung Lee; Woon Won Jung; Seok-Ho Dong; Hyo-Jong Kim; Byung-Ho Kim; Joung-Il Lee; Rin Chang
Journal:  Int J Cancer       Date:  2005-04-10       Impact factor: 7.396

Review 5.  XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.

Authors:  Zhibin Hu; Hongxia Ma; Feng Chen; Qingyi Wei; Hongbing Shen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

6.  Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B -31 C/+ and IL-1RN *2/*2) and gastric cancer/duodenal ulcer in Korean population.

Authors:  Seong-Gene Lee; Byungsik Kim; Wonyong Choi; Inchul Lee; Jaewon Choi; Kyuyoung Song
Journal:  Cytokine       Date:  2003-02-21       Impact factor: 3.861

7.  Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer.

Authors:  A Chen; C-N Li; P-I Hsu; K-H Lai; H-H Tseng; P-N Hsu; G-H Lo; C-C Lo; C-K Lin; I-R Hwang; Y Yamaoka; H-C Chen
Journal:  Aliment Pharmacol Ther       Date:  2004-07-15       Impact factor: 8.171

8.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.

Authors:  Shioto Suzuki; Youko Muroishi; Isao Nakanishi; Yoshio Oda
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

10.  Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.

Authors:  S Kato; M Onda; N Matsukura; A Tokunaga; N Matsuda; K Yamashita; P G Shields
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

View more
  13 in total

1.  Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations.

Authors:  Jing He; Li-Xin Qiu; Meng-Yun Wang; Rui-Xi Hua; Ruo-Xin Zhang; Hong-Ping Yu; Ya-Nong Wang; Meng-Hong Sun; Xiao-Yan Zhou; Ya-Jun Yang; Jiu-Cun Wang; Li Jin; Qing-Yi Wei; Jin Li
Journal:  Hum Genet       Date:  2012-02-28       Impact factor: 4.132

Review 2.  Gene-diet interactions in gastric cancer risk: a systematic review.

Authors:  Jeongseon Kim; Young Ae Cho; Wook Jin Choi; Seung Hwa Jeong
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

3.  Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer.

Authors:  M S Al-Moundhri; I Al-Hadabi; K Al-Mawaly; S Kumar; F A R Al-Lawati; G Bhatnager; S Kuruvila; A Al-Hamdani; S M El-Sayed; B Al-Bahrani
Journal:  Med Oncol       Date:  2011-11-03       Impact factor: 3.064

4.  Absence of anaplastic lymphoma kinase translocations in signet ring cell carcinomas of the upper gastrointestinal tract.

Authors:  Jill Miller; Zhihua Peng; Rebecca Wilcox; Mark Evans; Steven Ades; Claire Verschraegen
Journal:  Gastrointest Cancer Res       Date:  2014-03

Review 5.  Medical management of gastric cancer: a 2014 update.

Authors:  Elena Elimova; Hironori Shiozaki; Roopma Wadhwa; Kazuki Sudo; Qiongrong Chen; Jeannelyn S Estrella; Mariela A Blum; Brian Badgwell; Prajnan Das; Shumei Song; Jaffer A Ajani
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 6.  Gastric cancer-molecular and clinical dimensions.

Authors:  Roopma Wadhwa; Shumei Song; Ju-Seog Lee; Yixin Yao; Qingyi Wei; Jaffer A Ajani
Journal:  Nat Rev Clin Oncol       Date:  2013-09-24       Impact factor: 66.675

7.  Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.

Authors:  Jing He; Yu Xu; Li-Xin Qiu; Jin Li; Xiao-Yan Zhou; Meng-Hong Sun; Jiu-Cun Wang; Ya-Jun Yang; Li Jin; Qing-Yi Wei; Yanong Wang
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

8.  Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population.

Authors:  Mengyun Wang; Ruoxin Zhang; Jing He; Lixin Qiu; Jin Li; Yanong Wang; Menghong Sun; Yajun Yang; Jiucun Wang; Jingmin Yang; Ji Qian; Li Jin; Hongxia Ma; Qingyi Wei; Xiaoyan Zhou
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

9.  The Influence of PSCA Gene Variation on Its Expression and Gastric Adenocarcinoma Susceptibility in the Northwest Chinese Population.

Authors:  Wentao Zhang; Ping Liang; Weihua Wang; Peng Dai; Qin Wang; Wei Yan; Jinrong Zhao; Jianbin Sun; Yong Peng; Daxiang Cui; Zhen Yan
Journal:  Int J Mol Sci       Date:  2015-05-21       Impact factor: 5.923

10.  Potentially functional polymorphisms in the CASP7 gene contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population.

Authors:  Meng-Yun Wang; Mei-Ling Zhu; Jing He; Ting-Yan Shi; Qiao-Xin Li; Ya-Nong Wang; Jin Li; Xiao-Yan Zhou; Meng-Hong Sun; Xiao-Feng Wang; Ya-Jun Yang; Jiu-Cun Wang; Li Jin; Qing-Yi Wei
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.